These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10226930)

  • 1. Should we genetically test everyone for haemochromatosis?
    Allen K; Williamson R
    J Med Ethics; 1999 Apr; 25(2):209-14. PubMed ID: 10226930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and the new genetics; a public health perspective on the ethical debate.
    Stone DH; Stewart S
    J Public Health Med; 1996 Mar; 18(1):3-5. PubMed ID: 8785072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of haemochromatosis gene mutations in the general population: implications for screening.
    Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA
    Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: targeted screening for hereditary haemochromatosis in high-risk groups.
    DuBois S; Kowdley KV
    Aliment Pharmacol Ther; 2004 Jul; 20(1):1-14. PubMed ID: 15225165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    Health Technol Assess; 2009 Apr; 13(23):iii, ix-xi, 1-126. PubMed ID: 19406046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility screening in schools: attitudes of the school community towards hereditary haemochromatosis.
    Gason AA; Aitken MA; Metcalfe SA; Allen KJ; Delatycki MB
    Clin Genet; 2005 Feb; 67(2):166-74. PubMed ID: 15679829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations.
    Cooper K; Bryant J; Picot J; Clegg A; Roderick PR; Rosenberg WM; Patch C
    QJM; 2008 Aug; 101(8):631-41. PubMed ID: 18522976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptance of neonatal genetic screening for hereditary hemochromatosis by informed parents.
    Bassett M; Dunn C; Battese K; Peek M
    Genet Test; 2001; 5(4):317-20. PubMed ID: 11960577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hereditary haemochromatosis should be implemented now.
    Allen K; Williamson R
    BMJ; 2000 Jan; 320(7228):183-4. PubMed ID: 10634748
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical issues with genetic testing in pediatrics.
    Committee on Bioethics
    Pediatrics; 2001 Jun; 107(6):1451-5. PubMed ID: 11389275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Bhavnani M; Lloyd D; Bhattacharyya A; Marples J; Elton P; Worwood M
    Gut; 2000 May; 46(5):707-10. PubMed ID: 10764716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of HaemScreen, a workplace-based genetic screening program for hemochromatosis.
    Nisselle AE; Delatycki MB; Collins V; Metcalfe S; Aitken MA; du Sart D; Halliday J; Macciocca I; Wakefield A; Hill V; Gason A; Warner B; Calabro V; Williamson R; Allen KJ
    Clin Genet; 2004 May; 65(5):358-67. PubMed ID: 15099342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    J Med Genet; 2008 Aug; 45(8):513-8. PubMed ID: 18310265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism.
    Kelly AL; Lunt PW; Rodrigues F; Berry PJ; Flynn DM; McKiernan PJ; Kelly DA; Mieli-Vergani G; Cox TM
    J Med Genet; 2001 Sep; 38(9):599-610. PubMed ID: 11546828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis.
    Whitington PF; Hibbard JU
    Lancet; 2004 Nov 6-12; 364(9446):1690-8. PubMed ID: 15530630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA testing for haemochromatosis: diagnostic, predictive and screening implications.
    Trent RJ; Le H; Yu B; Young G; Bowden DK
    Pathology; 2000 Nov; 32(4):274-9. PubMed ID: 11186424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa.
    de Villiers JN; Hillerman R; de Jong G; Langenhoven E; Rossouw H; Marx MP; Kotze MJ
    S Afr Med J; 1999 Mar; 89(3):279-82. PubMed ID: 10226674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.